VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Organon & Co. (OGN) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceuticals · market value about $3.6B · P/E 18.0 · revenue $6.1B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows